Key trials in prostate cancer at ASCO 2022

Описание: Arun Azad, MBBS, PhD, FRACP, Peter MacCallum Cancer Centre, Victoria, Australia, discusses which trials in prostate cancer to look out for at ASCO 2022, including TheraP (NCT03392428), VISION (NCT03511664), and ENZAMET (NCT02446405). This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.